Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
From clinical imaging to implantation of 3D printed tissues.

Nature biotechnology

Pashuck ET, Stevens M.
PMID: 26963553
Nat Biotechnol. 2016 Mar;34(3):295-6. doi: 10.1038/nbt.3503.

No abstract available.

Cite
Pashuck ET, Stevens M. From clinical imaging to implantation of 3D printed tissues. Nat Biotechnol. 2016;34(3):295-6doi: 10.1038/nbt.3503.
Pashuck, E. T., & Stevens, M. (2016). From clinical imaging to implantation of 3D printed tissues. Nature biotechnology, 34(3), 295-6. https://doi.org/10.1038/nbt.3503
Pashuck, E Thomas, and Stevens, Molly. "From clinical imaging to implantation of 3D printed tissues." Nature biotechnology vol. 34,3 (2016): 295-6. doi: https://doi.org/10.1038/nbt.3503
Pashuck ET, Stevens M. From clinical imaging to implantation of 3D printed tissues. Nat Biotechnol. 2016 Mar;34(3):295-6. doi: 10.1038/nbt.3503. PMID: 26963553.
Copy Download .nbib Format: NLM
[No title available]

Tissue engineering. Part A

Gingery A, Killian ML.
PMID: 28925856
Tissue Eng Part A. 2017 Sep;23(17):873.

No abstract available.

Cite
Gingery A, Killian ML. . Tissue Eng Part A. 2017;23(17):873
Gingery, A., & Killian, M. L. (2017). . Tissue engineering. Part A, 23(17), 873.
Gingery, Anne, and Killian, Megan L. "." Tissue engineering. Part A vol. 23,17 (2017): 873.
Gingery A, Killian ML. . Tissue Eng Part A. 2017 Sep;23(17):873. PMID: 28925856.
Copy Download .nbib Format: NLM
Micropatterned nanostructures: a bioengineered approach to mass-produce functional myocardial grafts.

Nanotechnology

Serpooshan V, Mahmoudi M.
PMID: 25611345
Nanotechnology. 2015 Feb 13;26(6):060501. doi: 10.1088/0957-4484/26/6/060501. Epub 2015 Jan 22.

Cell-based therapies are a recently established path for treating a wide range of human disease. Tissue engineering of contractile heart muscle for replacement therapy is among the most exciting and important of these efforts. However, current in vitro techniques...

Cite
Serpooshan V, Mahmoudi M. Micropatterned nanostructures: a bioengineered approach to mass-produce functional myocardial grafts. Nanotechnology. 2015;26(6):060501doi: 10.1088/0957-4484/26/6/060501.
Serpooshan, V., & Mahmoudi, M. (2015). Micropatterned nanostructures: a bioengineered approach to mass-produce functional myocardial grafts. Nanotechnology, 26(6), 060501. https://doi.org/10.1088/0957-4484/26/6/060501
Serpooshan, Vahid, and Mahmoudi, Morteza. "Micropatterned nanostructures: a bioengineered approach to mass-produce functional myocardial grafts." Nanotechnology vol. 26,6 (2015): 060501. doi: https://doi.org/10.1088/0957-4484/26/6/060501
Serpooshan V, Mahmoudi M. Micropatterned nanostructures: a bioengineered approach to mass-produce functional myocardial grafts. Nanotechnology. 2015 Feb 13;26(6):060501. doi: 10.1088/0957-4484/26/6/060501. Epub 2015 Jan 22. PMID: 25611345.
Copy Download .nbib Format: NLM
Advances in tissue engineering.

Journal of pediatric surgery

Langer R, Vacanti J.
PMID: 26711689
J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10.

Nearly 30 years ago, we reported on a concept now known as Tissue Engineering. Here, we report on some of the advances in this now thriving area of research. In particular, significant advances in tissue engineering of skin, liver,...

Cite
Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2015;51(1):8-12doi: 10.1016/j.jpedsurg.2015.10.022.
Langer, R., & Vacanti, J. (2016). Advances in tissue engineering. Journal of pediatric surgery, 51(1), 8-12. https://doi.org/10.1016/j.jpedsurg.2015.10.022
Langer, Robert, and Vacanti, Joseph. "Advances in tissue engineering." Journal of pediatric surgery vol. 51,1 (2016): 8-12. doi: https://doi.org/10.1016/j.jpedsurg.2015.10.022
Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.
Copy Download .nbib Format: NLM
Regenerative medicine: is this the biggest change in surgery?.

Seminars in pediatric surgery

De Coppi P, Grikscheit TC.
PMID: 24994522
Semin Pediatr Surg. 2014 Jun;23(3):103-5. doi: 10.1053/j.sempedsurg.2014.04.001. Epub 2014 Apr 18.

No abstract available.

Cite
De Coppi P, Grikscheit TC. Regenerative medicine: is this the biggest change in surgery?. Semin Pediatr Surg. 2014;23(3):103-5doi: 10.1053/j.sempedsurg.2014.04.001.
De Coppi, P., & Grikscheit, T. C. (2014). Regenerative medicine: is this the biggest change in surgery?. Seminars in pediatric surgery, 23(3), 103-5. https://doi.org/10.1053/j.sempedsurg.2014.04.001
De Coppi, Paolo, and Grikscheit, T C. "Regenerative medicine: is this the biggest change in surgery?." Seminars in pediatric surgery vol. 23,3 (2014): 103-5. doi: https://doi.org/10.1053/j.sempedsurg.2014.04.001
De Coppi P, Grikscheit TC. Regenerative medicine: is this the biggest change in surgery?. Semin Pediatr Surg. 2014 Jun;23(3):103-5. doi: 10.1053/j.sempedsurg.2014.04.001. Epub 2014 Apr 18. PMID: 24994522.
Copy Download .nbib Format: NLM
Standardized 3D Bioprinting of Soft Tissue Models with Human Primary Cells.

Journal of laboratory automation

Rimann M, Bono E, Annaheim H, Bleisch M, Graf-Hausner U.
PMID: 25609254
J Lab Autom. 2016 Aug;21(4):496-509. doi: 10.1177/2211068214567146. Epub 2015 Jan 21.

Cells grown in 3D are more physiologically relevant than cells cultured in 2D. To use 3D models in substance testing and regenerative medicine, reproducibility and standardization are important. Bioprinting offers not only automated standardizable processes but also the production...

Cite
Rimann M, Bono E, Annaheim H, et al. Standardized 3D Bioprinting of Soft Tissue Models with Human Primary Cells. J Lab Autom. 2015;21(4):496-509doi: 10.1177/2211068214567146.
Rimann, M., Bono, E., Annaheim, H., Bleisch, M., & Graf-Hausner, U. (2016). Standardized 3D Bioprinting of Soft Tissue Models with Human Primary Cells. Journal of laboratory automation, 21(4), 496-509. https://doi.org/10.1177/2211068214567146
Rimann, Markus, et al. "Standardized 3D Bioprinting of Soft Tissue Models with Human Primary Cells." Journal of laboratory automation vol. 21,4 (2016): 496-509. doi: https://doi.org/10.1177/2211068214567146
Rimann M, Bono E, Annaheim H, Bleisch M, Graf-Hausner U. Standardized 3D Bioprinting of Soft Tissue Models with Human Primary Cells. J Lab Autom. 2016 Aug;21(4):496-509. doi: 10.1177/2211068214567146. Epub 2015 Jan 21. PMID: 25609254.
Copy Download .nbib Format: NLM
Tissue engineering: perspectives, challenges, and future directions.

Tissue engineering

Langer R.
PMID: 17518575
Tissue Eng. 2007 Jan;13(1):1-2. doi: 10.1089/ten.2006.0219.

No abstract available.

Cite
Langer R. Tissue engineering: perspectives, challenges, and future directions. Tissue Eng. 2007;13(1):1-2doi: 10.1089/ten.2006.0219.
Langer, R. (2007). Tissue engineering: perspectives, challenges, and future directions. Tissue engineering, 13(1), 1-2. https://doi.org/10.1089/ten.2006.0219
Langer, Robert. "Tissue engineering: perspectives, challenges, and future directions." Tissue engineering vol. 13,1 (2007): 1-2. doi: https://doi.org/10.1089/ten.2006.0219
Langer R. Tissue engineering: perspectives, challenges, and future directions. Tissue Eng. 2007 Jan;13(1):1-2. doi: 10.1089/ten.2006.0219. PMID: 17518575.
Copy Download .nbib Format: NLM
Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds.

Tissue engineering. Part A

Abrahamsson CK, Yang F, Park H, Brunger JM, Valonen PK, Langer R, Welter JF, Caplan AI, Guilak F, Freed LE.
PMID: 20673022
Tissue Eng Part A. 2010 Dec;16(12):3709-18. doi: 10.1089/ten.TEA.2010.0190. Epub 2010 Sep 06.

Human mesenchymal stem cells (hMSCs) and three-dimensional (3D) woven poly(ɛ-caprolactone) (PCL) scaffolds are promising tools for skeletal tissue engineering. We hypothesized that in vitro culture duration and medium additives can individually and interactively influence the structure, composition, mechanical, and...

Cite
Abrahamsson CK, Yang F, Park H, et al. Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue Eng Part A. 2010;16(12):3709-18doi: 10.1089/ten.TEA.2010.0190.
Abrahamsson, C. K., Yang, F., Park, H., Brunger, J. M., Valonen, P. K., Langer, R., Welter, J. F., Caplan, A. I., Guilak, F., & Freed, L. E. (2010). Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue engineering. Part A, 16(12), 3709-18. https://doi.org/10.1089/ten.TEA.2010.0190
Abrahamsson, Christoffer K, et al. "Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds." Tissue engineering. Part A vol. 16,12 (2010): 3709-18. doi: https://doi.org/10.1089/ten.TEA.2010.0190
Abrahamsson CK, Yang F, Park H, Brunger JM, Valonen PK, Langer R, Welter JF, Caplan AI, Guilak F, Freed LE. Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue Eng Part A. 2010 Dec;16(12):3709-18. doi: 10.1089/ten.TEA.2010.0190. Epub 2010 Sep 06. PMID: 20673022; PMCID: PMC2991213.
Copy Download .nbib Format: NLM
Nanotechnology in pediatrics: science fiction or reality?.

Journal of pediatric nursing

Mele C.
PMID: 21726790
J Pediatr Nurs. 2011 Aug;26(4):379-82. doi: 10.1016/j.pedn.2011.04.028.

No abstract available.

Cite
Mele C. Nanotechnology in pediatrics: science fiction or reality?. J Pediatr Nurs. 2011;26(4):379-82doi: 10.1016/j.pedn.2011.04.028.
Mele, C. (2011). Nanotechnology in pediatrics: science fiction or reality?. Journal of pediatric nursing, 26(4), 379-82. https://doi.org/10.1016/j.pedn.2011.04.028
Mele, Cheryl. "Nanotechnology in pediatrics: science fiction or reality?." Journal of pediatric nursing vol. 26,4 (2011): 379-82. doi: https://doi.org/10.1016/j.pedn.2011.04.028
Mele C. Nanotechnology in pediatrics: science fiction or reality?. J Pediatr Nurs. 2011 Aug;26(4):379-82. doi: 10.1016/j.pedn.2011.04.028. PMID: 21726790.
Copy Download .nbib Format: NLM
Carbon nanotubes in medicine & biology - therapy and diagnostics.

Advanced drug delivery reviews

Ali-Boucetta H, Kostarelos K.
PMID: 24220279
Adv Drug Deliv Rev. 2013 Dec;65(15):1897-8. doi: 10.1016/j.addr.2013.11.002. Epub 2013 Nov 09.

No abstract available.

Cite
Ali-Boucetta H, Kostarelos K. Carbon nanotubes in medicine & biology - therapy and diagnostics. Adv Drug Deliv Rev. 2013;65(15):1897-8doi: 10.1016/j.addr.2013.11.002.
Ali-Boucetta, H., & Kostarelos, K. (2013). Carbon nanotubes in medicine & biology - therapy and diagnostics. Advanced drug delivery reviews, 65(15), 1897-8. https://doi.org/10.1016/j.addr.2013.11.002
Ali-Boucetta, Hanene, and Kostarelos, Kostas. "Carbon nanotubes in medicine & biology - therapy and diagnostics." Advanced drug delivery reviews vol. 65,15 (2013): 1897-8. doi: https://doi.org/10.1016/j.addr.2013.11.002
Ali-Boucetta H, Kostarelos K. Carbon nanotubes in medicine & biology - therapy and diagnostics. Adv Drug Deliv Rev. 2013 Dec;65(15):1897-8. doi: 10.1016/j.addr.2013.11.002. Epub 2013 Nov 09. PMID: 24220279.
Copy Download .nbib Format: NLM
Driving the bumpy road to commercialization.

Tissue engineering. Part A

Parenteau NL.
PMID: 24735453
Tissue Eng Part A. 2014 Jun;20(11):1563-4. doi: 10.1089/ten.tea.2014.0012. Epub 2014 Apr 15.

Tissue engineering has always had an applied focus and there is hardly an academic publication that does not mention the applicability of its findings to the future development of a medical product. I have been involved in the industry...

Cite
Parenteau NL. Driving the bumpy road to commercialization. Tissue Eng Part A. 2014;20(11):1563-4doi: 10.1089/ten.tea.2014.0012.
Parenteau, N. L. (2014). Driving the bumpy road to commercialization. Tissue engineering. Part A, 20(11), 1563-4. https://doi.org/10.1089/ten.tea.2014.0012
Parenteau, Nancy L. "Driving the bumpy road to commercialization." Tissue engineering. Part A vol. 20,11 (2014): 1563-4. doi: https://doi.org/10.1089/ten.tea.2014.0012
Parenteau NL. Driving the bumpy road to commercialization. Tissue Eng Part A. 2014 Jun;20(11):1563-4. doi: 10.1089/ten.tea.2014.0012. Epub 2014 Apr 15. PMID: 24735453.
Copy Download .nbib Format: NLM
Tissue therapeutics and regenerative medicine.

Drug discovery today

Jayasinghe SN.
PMID: 24735731
Drug Discov Today. 2014 Jun;19(6):711-3. doi: 10.1016/j.drudis.2014.04.003. Epub 2014 Apr 13.

No abstract available.

Cite
Jayasinghe SN. Tissue therapeutics and regenerative medicine. Drug Discov Today. 2014;19(6):711-3doi: 10.1016/j.drudis.2014.04.003.
Jayasinghe, S. N. (2014). Tissue therapeutics and regenerative medicine. Drug discovery today, 19(6), 711-3. https://doi.org/10.1016/j.drudis.2014.04.003
Jayasinghe, Suwan N. "Tissue therapeutics and regenerative medicine." Drug discovery today vol. 19,6 (2014): 711-3. doi: https://doi.org/10.1016/j.drudis.2014.04.003
Jayasinghe SN. Tissue therapeutics and regenerative medicine. Drug Discov Today. 2014 Jun;19(6):711-3. doi: 10.1016/j.drudis.2014.04.003. Epub 2014 Apr 13. PMID: 24735731.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries